Fungicidal effect of three new synthetic cationic peptides against Candida albicans

H. Nikawa, H. Fakashima, Seicho Makihira, T. Hamada, L. P. Samaranayake

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

OBJECTIVE: Peptide antibiotics are considered a new class of antifungal agents. Of these, an α-helical, cationic peptide termed Dhvar 4, a relative of salivary histatin has been shown to be an antifungal of relatively high potency. Similarly, lactoferricin B (LFB) and a derivative thereof, LFB(17-30), disrupts the fungal cell membrane and acts against Candida albicans. As Dhvar 4 and LFB(17-30), exhibit almost identical amino acid sequences at their C-terminal, we hypothesized that laboratory synthesis of peptides with an α-helical structure and having similar amphipathic properties could lead to products with candidacidal activity. Hence, three such peptides - JH8194, JH8195 and JH 8944, were synthesized and their antifungal properties compared with recognized antifungals LFB, LFB(17-30), human lactoferricin (LFH), Histatin-5 and Dhvar 4, against two isolates of C. albicans. MATERIALS AND METHODS: The antifungal agents were synthesized and their secondary structures evaluated according to a previously described protocol of Situ and Bobek (2000) Antimicrob Agents Chemother 44: 1485-1493. The C. albicans strains were oral isolates from a human immunodeficiency virus-infected (isolate A2) and a healthy (A6) individual. A standard concentration of yeasts was exposed to a range of dilutions of the agents for a specific duration and the cell death (viability) in terms of the resultant colony forming units ml-1 was quantified. RESULTS: Dhvar 4, showed the most α-helical propensity, and was the least fungicidal while LFB and LFB(17-30) showed the highest antifungal potential, and demonstrated total kill of A6, and A2 at 5 and 10 μM concentrations, respectively whilst LFH killed both isolates at a 10 μM concentration. Of the three new synthetic peptides, JH 8194 was the most potent (total kill of A6/A2 strains at 1.25/2.5 μM), followed by JH 8195 (total kill of A6/A2 strains at 5/10 μM while JH 8944 was the least potent as a 25 μM concentration was required to kill either strain of Candida. On further analyses of the relationship between pl value of the peptides and their anticandicidal activity, a significant positive correlation was noted. In order to rule out a cytotoxic effect of the new synthetic peptides we compared the fungicidal and hemolytic activities under similar incubation conditions using freshly isolated erythrocytes and all three peptides exhibited no detectable hemolysis upto an concentration of 100 μM in contrast to the polyene antifungal amphotericin B that elicited significant initiation of hemolysis at a concentration of 5.0 μM. CONCLUSION: Our data suggest that laboratory synthesis of agents with an α-helical structure and having amphipathic properties similar to known, natural antifungal agents may be a promising avenue to generate products with improved antifungal activity.

Original languageEnglish
Pages (from-to)221-228
Number of pages8
JournalOral Diseases
Volume10
Issue number4
DOIs
Publication statusPublished - Jul 1 2004

Fingerprint

Candida albicans
Peptides
varespladib methyl
Antifungal Agents
Histatins
Hemolysis
Polyenes
lactoferricin B
Amphotericin B
Candida
Amino Acid Sequence
Cell Survival
Cell Death
Stem Cells
Yeasts
Erythrocytes
Cell Membrane
HIV
Anti-Bacterial Agents
lactoferricin (17-30)

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology
  • Dentistry(all)

Cite this

Nikawa, H., Fakashima, H., Makihira, S., Hamada, T., & Samaranayake, L. P. (2004). Fungicidal effect of three new synthetic cationic peptides against Candida albicans. Oral Diseases, 10(4), 221-228. https://doi.org/10.1111/j.1601-0825.2004.01010.x

Fungicidal effect of three new synthetic cationic peptides against Candida albicans. / Nikawa, H.; Fakashima, H.; Makihira, Seicho; Hamada, T.; Samaranayake, L. P.

In: Oral Diseases, Vol. 10, No. 4, 01.07.2004, p. 221-228.

Research output: Contribution to journalArticle

Nikawa, H, Fakashima, H, Makihira, S, Hamada, T & Samaranayake, LP 2004, 'Fungicidal effect of three new synthetic cationic peptides against Candida albicans', Oral Diseases, vol. 10, no. 4, pp. 221-228. https://doi.org/10.1111/j.1601-0825.2004.01010.x
Nikawa, H. ; Fakashima, H. ; Makihira, Seicho ; Hamada, T. ; Samaranayake, L. P. / Fungicidal effect of three new synthetic cationic peptides against Candida albicans. In: Oral Diseases. 2004 ; Vol. 10, No. 4. pp. 221-228.
@article{32137a18b3fd403f83296db13abeb1de,
title = "Fungicidal effect of three new synthetic cationic peptides against Candida albicans",
abstract = "OBJECTIVE: Peptide antibiotics are considered a new class of antifungal agents. Of these, an α-helical, cationic peptide termed Dhvar 4, a relative of salivary histatin has been shown to be an antifungal of relatively high potency. Similarly, lactoferricin B (LFB) and a derivative thereof, LFB(17-30), disrupts the fungal cell membrane and acts against Candida albicans. As Dhvar 4 and LFB(17-30), exhibit almost identical amino acid sequences at their C-terminal, we hypothesized that laboratory synthesis of peptides with an α-helical structure and having similar amphipathic properties could lead to products with candidacidal activity. Hence, three such peptides - JH8194, JH8195 and JH 8944, were synthesized and their antifungal properties compared with recognized antifungals LFB, LFB(17-30), human lactoferricin (LFH), Histatin-5 and Dhvar 4, against two isolates of C. albicans. MATERIALS AND METHODS: The antifungal agents were synthesized and their secondary structures evaluated according to a previously described protocol of Situ and Bobek (2000) Antimicrob Agents Chemother 44: 1485-1493. The C. albicans strains were oral isolates from a human immunodeficiency virus-infected (isolate A2) and a healthy (A6) individual. A standard concentration of yeasts was exposed to a range of dilutions of the agents for a specific duration and the cell death (viability) in terms of the resultant colony forming units ml-1 was quantified. RESULTS: Dhvar 4, showed the most α-helical propensity, and was the least fungicidal while LFB and LFB(17-30) showed the highest antifungal potential, and demonstrated total kill of A6, and A2 at 5 and 10 μM concentrations, respectively whilst LFH killed both isolates at a 10 μM concentration. Of the three new synthetic peptides, JH 8194 was the most potent (total kill of A6/A2 strains at 1.25/2.5 μM), followed by JH 8195 (total kill of A6/A2 strains at 5/10 μM while JH 8944 was the least potent as a 25 μM concentration was required to kill either strain of Candida. On further analyses of the relationship between pl value of the peptides and their anticandicidal activity, a significant positive correlation was noted. In order to rule out a cytotoxic effect of the new synthetic peptides we compared the fungicidal and hemolytic activities under similar incubation conditions using freshly isolated erythrocytes and all three peptides exhibited no detectable hemolysis upto an concentration of 100 μM in contrast to the polyene antifungal amphotericin B that elicited significant initiation of hemolysis at a concentration of 5.0 μM. CONCLUSION: Our data suggest that laboratory synthesis of agents with an α-helical structure and having amphipathic properties similar to known, natural antifungal agents may be a promising avenue to generate products with improved antifungal activity.",
author = "H. Nikawa and H. Fakashima and Seicho Makihira and T. Hamada and Samaranayake, {L. P.}",
year = "2004",
month = "7",
day = "1",
doi = "10.1111/j.1601-0825.2004.01010.x",
language = "English",
volume = "10",
pages = "221--228",
journal = "Oral Diseases",
issn = "1354-523X",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Fungicidal effect of three new synthetic cationic peptides against Candida albicans

AU - Nikawa, H.

AU - Fakashima, H.

AU - Makihira, Seicho

AU - Hamada, T.

AU - Samaranayake, L. P.

PY - 2004/7/1

Y1 - 2004/7/1

N2 - OBJECTIVE: Peptide antibiotics are considered a new class of antifungal agents. Of these, an α-helical, cationic peptide termed Dhvar 4, a relative of salivary histatin has been shown to be an antifungal of relatively high potency. Similarly, lactoferricin B (LFB) and a derivative thereof, LFB(17-30), disrupts the fungal cell membrane and acts against Candida albicans. As Dhvar 4 and LFB(17-30), exhibit almost identical amino acid sequences at their C-terminal, we hypothesized that laboratory synthesis of peptides with an α-helical structure and having similar amphipathic properties could lead to products with candidacidal activity. Hence, three such peptides - JH8194, JH8195 and JH 8944, were synthesized and their antifungal properties compared with recognized antifungals LFB, LFB(17-30), human lactoferricin (LFH), Histatin-5 and Dhvar 4, against two isolates of C. albicans. MATERIALS AND METHODS: The antifungal agents were synthesized and their secondary structures evaluated according to a previously described protocol of Situ and Bobek (2000) Antimicrob Agents Chemother 44: 1485-1493. The C. albicans strains were oral isolates from a human immunodeficiency virus-infected (isolate A2) and a healthy (A6) individual. A standard concentration of yeasts was exposed to a range of dilutions of the agents for a specific duration and the cell death (viability) in terms of the resultant colony forming units ml-1 was quantified. RESULTS: Dhvar 4, showed the most α-helical propensity, and was the least fungicidal while LFB and LFB(17-30) showed the highest antifungal potential, and demonstrated total kill of A6, and A2 at 5 and 10 μM concentrations, respectively whilst LFH killed both isolates at a 10 μM concentration. Of the three new synthetic peptides, JH 8194 was the most potent (total kill of A6/A2 strains at 1.25/2.5 μM), followed by JH 8195 (total kill of A6/A2 strains at 5/10 μM while JH 8944 was the least potent as a 25 μM concentration was required to kill either strain of Candida. On further analyses of the relationship between pl value of the peptides and their anticandicidal activity, a significant positive correlation was noted. In order to rule out a cytotoxic effect of the new synthetic peptides we compared the fungicidal and hemolytic activities under similar incubation conditions using freshly isolated erythrocytes and all three peptides exhibited no detectable hemolysis upto an concentration of 100 μM in contrast to the polyene antifungal amphotericin B that elicited significant initiation of hemolysis at a concentration of 5.0 μM. CONCLUSION: Our data suggest that laboratory synthesis of agents with an α-helical structure and having amphipathic properties similar to known, natural antifungal agents may be a promising avenue to generate products with improved antifungal activity.

AB - OBJECTIVE: Peptide antibiotics are considered a new class of antifungal agents. Of these, an α-helical, cationic peptide termed Dhvar 4, a relative of salivary histatin has been shown to be an antifungal of relatively high potency. Similarly, lactoferricin B (LFB) and a derivative thereof, LFB(17-30), disrupts the fungal cell membrane and acts against Candida albicans. As Dhvar 4 and LFB(17-30), exhibit almost identical amino acid sequences at their C-terminal, we hypothesized that laboratory synthesis of peptides with an α-helical structure and having similar amphipathic properties could lead to products with candidacidal activity. Hence, three such peptides - JH8194, JH8195 and JH 8944, were synthesized and their antifungal properties compared with recognized antifungals LFB, LFB(17-30), human lactoferricin (LFH), Histatin-5 and Dhvar 4, against two isolates of C. albicans. MATERIALS AND METHODS: The antifungal agents were synthesized and their secondary structures evaluated according to a previously described protocol of Situ and Bobek (2000) Antimicrob Agents Chemother 44: 1485-1493. The C. albicans strains were oral isolates from a human immunodeficiency virus-infected (isolate A2) and a healthy (A6) individual. A standard concentration of yeasts was exposed to a range of dilutions of the agents for a specific duration and the cell death (viability) in terms of the resultant colony forming units ml-1 was quantified. RESULTS: Dhvar 4, showed the most α-helical propensity, and was the least fungicidal while LFB and LFB(17-30) showed the highest antifungal potential, and demonstrated total kill of A6, and A2 at 5 and 10 μM concentrations, respectively whilst LFH killed both isolates at a 10 μM concentration. Of the three new synthetic peptides, JH 8194 was the most potent (total kill of A6/A2 strains at 1.25/2.5 μM), followed by JH 8195 (total kill of A6/A2 strains at 5/10 μM while JH 8944 was the least potent as a 25 μM concentration was required to kill either strain of Candida. On further analyses of the relationship between pl value of the peptides and their anticandicidal activity, a significant positive correlation was noted. In order to rule out a cytotoxic effect of the new synthetic peptides we compared the fungicidal and hemolytic activities under similar incubation conditions using freshly isolated erythrocytes and all three peptides exhibited no detectable hemolysis upto an concentration of 100 μM in contrast to the polyene antifungal amphotericin B that elicited significant initiation of hemolysis at a concentration of 5.0 μM. CONCLUSION: Our data suggest that laboratory synthesis of agents with an α-helical structure and having amphipathic properties similar to known, natural antifungal agents may be a promising avenue to generate products with improved antifungal activity.

UR - http://www.scopus.com/inward/record.url?scp=3042755651&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042755651&partnerID=8YFLogxK

U2 - 10.1111/j.1601-0825.2004.01010.x

DO - 10.1111/j.1601-0825.2004.01010.x

M3 - Article

C2 - 15196144

AN - SCOPUS:3042755651

VL - 10

SP - 221

EP - 228

JO - Oral Diseases

JF - Oral Diseases

SN - 1354-523X

IS - 4

ER -